| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,750 | 6,646 | 13,631 | 63,533 | 96,300 |
| Selling, General and Administrative Expenses
|
-37,122 | -46,521 | -74,169 | -81,448 | -84,232 |
|
Research and Development Expenses
|
-98,730 | -107,829 | -135,001 | -172,596 | -320,454 |
|
Operating Income/Expenses
|
-135,852 | -154,350 | -209,170 | -254,044 | -404,686 |
|
Total Operating Profit/Loss
|
-131,102 | -147,704 | -195,539 | -190,511 | -308,386 |
| Total Net Finance Income/Expense
|
7,051 | 11,052 | 17,288 | 17,186 | 5,842 |
| Net Investment Income
|
244 | 244 | 819 | 2,515 | 20,307 |
| Irregular Income/Expenses
|
0 | 0 | -14,737 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
-626 | 93 | 5,907 | 9,882 | 516 |
|
Non-Operating Income/Expenses, Total
|
6,669 | 11,389 | 9,277 | 29,583 | 26,665 |
|
Pretax Income
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
|
Net Income from Continuing Operations
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
|
Net Income after Non-Controlling/Minority Interests
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
|
Net Income Available to Common Stockholders
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
|
Diluted Net Income Available to Common Stockholders
|
-124,433 | -136,315 | -186,262 | -160,928 | -281,721 |
| Basic EPS
|
-1.03 | -1.15 | -1.64 | -1.64 | -2.91 |
| Diluted EPS
|
-1.03 | -1.15 | -1.64 | -1.64 | -2.91 |
|
Basic Weighted Average Shares Outstanding
|
120,843.8640 | 118,789.9740 | 113,685.1770 | 98,411.1620 | 96,826.0580 |
|
Diluted Weighted Average Shares Outstanding
|
120,843.8640 | 118,789.9740 | 113,685.1770 | 98,411.1620 | 96,826.0580 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-131,484 | -147,367 | -203,550 | -178,114 | -287,563 |
|
EBITDA
|
-120,045 | -134,466 | -184,550 | -159,814 | -273,805 |
|
Normalized EBITDA
|
-104,327 | -109,777 | -128,194 | -118,870 | -215,379 |
|
Normalized Income
|
-108,715 | -111,626 | -129,906 | -119,984 | -223,295 |
|
Total Unusual Items
|
15,718 | 24,689 | 56,356 | 40,944 | 58,426 |
|
Total Unusual Items Excluding Goodwill
|
15,718 | 24,689 | 56,356 | 40,944 | 58,426 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 10/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade